Baxter International's Rocky Road: Can the Healthcare Giant Regain Wall Street's Confidence?
After a punishing year of underperformance and operational setbacks, Baxter International faces a skeptical analyst community. While some see deep value, the consensus remains firmly on hold as the company navigates product challenges and revised guidance.